For the second quarter, adjusted earnings per share increased 24.2% to $1.59.
This quarter, IBNR releases amounted to 5.6 percentage points impact on the benefit ratio, which leads to an underlying benefit ratio, excluding IBNR releases, of 49.1%.
At the same time, sales improved year-over-year for the first time during the pandemic in the second quarter in both the United States and Japan.
